These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16595769)

  • 1. The retinoic acid paradox in cancer chemoprevention.
    Freemantle SJ; Dragnev KH; Dmitrovsky E
    J Natl Cancer Inst; 2006 Apr; 98(7):426-7. PubMed ID: 16595769
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
    Kim ES; Hong WK
    J Natl Cancer Inst; 2005 Apr; 97(7):468-70. PubMed ID: 15812064
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoprevention of squamous cell carcinoma of the head and neck.
    Wrangle JM; Khuri FR
    Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids in chemoprevention of head and neck carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention strategies for lung and upper aerodigestive tract cancer.
    Benner SE; Lippman SM; Hong WK
    Cancer Res; 1992 May; 52(9 Suppl):2758s-2763s. PubMed ID: 1563008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly targeted approaches to the chemoprevention of lung cancer.
    Khuri FR; Cohen V
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.
    Jones E; Korzenko A; Kriegel D
    J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of head and neck cancer.
    Voravud N
    J Med Assoc Thai; 1996 Mar; 79(3):185-93. PubMed ID: 8708501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of chemoprevention of head and neck cancer.
    Benner SE; Lippman SM; Hong WK
    Oncology (Williston Park); 1992 Aug; 6(8):61-6; discussion 66-8, 71 passim. PubMed ID: 1386997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of oral squamous cell carcinomas.
    Scheer M; Kuebler AC; Zöller JE
    Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of a placebo run-in period in a head and neck cancer chemoprevention trial.
    Hudmon KS; Chamberlain RM; Frankowski RF
    Control Clin Trials; 1997 Jun; 18(3):228-40. PubMed ID: 9204223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancer chemoprevention gets a shot in the arm.
    Khuri FR; Shin DM
    J Clin Oncol; 2008 Jan; 26(3):345-7. PubMed ID: 18202405
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
    Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher potency of the synthetic retinoid MX3350-1 compared to the natural all-trans-retinoic acid in modulation of cell cycle and induction of apoptosis in head and neck squamous carcinoma cells.
    Chun KH; Lotan R
    Cell Death Differ; 2006 Oct; 13(10):1830-2. PubMed ID: 16601752
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Bhatia AK; Lee JW; Pinto HA; Jacobs CD; Limburg PJ; Rubin P; Arusell RM; Dunphy EP; Khandekar JD; Reiner SA; Baez-Diaz L; Celano P; Li S; Li Y; Burtness BA; Adams GL; Pandya KJ
    Cancer; 2017 Dec; 123(23):4653-4662. PubMed ID: 28786105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic retinoids: recent developments concerning structure and clinical utility.
    Kagechika H; Shudo K
    J Med Chem; 2005 Sep; 48(19):5875-83. PubMed ID: 16161990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.